gsk2292767 and Eosinophilia

gsk2292767 has been researched along with Eosinophilia* in 1 studies

Trials

1 trial(s) available for gsk2292767 and Eosinophilia

ArticleYear
Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase
    The Journal of pharmacology and experimental therapeutics, 2019, Volume: 369, Issue:3

    This study describes the pharmacokinetic (PK) and pharmaco-dynamic (PD) profile of

    Topics: Administration, Inhalation; Adult; Animals; Bronchoalveolar Lavage; Eosinophilia; Female; Humans; Indazoles; Lung; Male; Mice; Middle Aged; Permeability; Phosphoinositide-3 Kinase Inhibitors; Safety; Solubility; Sputum; Sulfonamides; Translational Research, Biomedical

2019